Entries by Max
Newsletter 36/2025
LAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week we have “only” four news items, but they are very good, especially the update on the ARCHES trial. Stay strong and fight on! As usual, we also have a podcast if you prefer to listen to the […]
Another Trial Supports Low-Dose Abiraterone Acetate in mCRPC
This study, published in JCO Global Oncology and focused on abiraterone acetate (AA), a drug used to treat metastatic castration-resistant prostate cancer, suggests that a smaller dose of AA is as effective as the standard dose (we already talked about another study pointing in the same direction in Singapore, but this sample is bigger). The […]
IND Required for ITC-6146RO for Solid Tumors Overexpressing the B7-H3 Protein
On August 29, 2025, a clinical trial plan (Investigational New Drug application) was submitted to the Ministry of Food and Drug Safety (MFDS) of South Korea to initiate phase 1 clinical trials for ITC-6146RO. ITC-6146RO is an antibody-drug conjugate (ADC) designed to target solid tumors overexpressing the B7-H3 protein, such as metastatic castration-resistant prostate cancer […]